What Reprint Nexus does

Reprint Nexus, Inc. is a privately held Atlanta, Georgia–based company founded in 2013 by Brian Christopher Bennett (President and Founder) that licenses and disseminates copyrighted scientific and medical content on behalf of healthcare and life sciences marketers. The company serves pharmaceutical and life sciences brands globally, with documented activity in international markets such as Spain via Eli Lilly España.

The company's core offering is the ECO Platform, a cloud-based Enterprise Content Ordering system that consolidates reprint fulfillment, eprint fulfillment, copyright permissions, and content translations into a single workflow. The platform is integrated with PubMed MEDLINE, allowing users to search the canonical biomedical citation database and order licensed content directly. Supporting services include Reprint Fulfillment, Eprint Fulfillment, Copyright Permissions, and Content Translations, addressing both the rights-clearance and the physical/digital distribution sides of scientific content reuse.

Reprint Nexus operates a hybrid go-to-market combining product-led usage of the ECO Platform with direct enterprise sales into pharma and life sciences brand and medical affairs teams. Revenue is generated through transactional fees on content orders and permissions, plus platform access for enterprise customers. The business runs with a 1–10 employee footprint, has no disclosed outside funding, and is positioned as a specialist intermediary between publishers/learned societies and brand teams that need compliant access to peer-reviewed content for marketing and sales use.

Name

Reprint Nexus

Legal name

Reprint Nexus, Inc.

Website

https://reprintnexus.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Reprint Nexus licenses and distributes copyrighted scientific and medical content for healthcare and life sciences marketing. It offers the ECO Platform, reprint and eprint fulfillment, copyright permissions, and content translations, serving pharmaceutical and life sciences companies globally from Atlanta, GA.

Ownership category

akta.pro rank

Product category

Copyright Content Licensing and Reprint Fulfillment

NAICS

Periodical Publishers (513120), Translation and Interpretation Services (541930), Commercial Printing (except Screen and Books) (323111)

SIC

Services-Mailing, Reproduction, Commercial Art & Photography (7330)

akta.pro primary industry

Content Syndication, Distribution & Rights Management Platforms (BPAMAJAN)

akta.pro secondary industry

Distribution Feeds & Syndication (Partner Delivery, APIs, Feeds) (MPAHALAJ)

Keywords

• Copyright content licensing
• Reprint fulfillment services
• Medical content distribution
• Pharmaceutical marketing services
• Collaborative group purchasing

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Reprint Fulfillment: Licensing, production, and fulfillment of bulk printed reprints sourced from publishers and learned societies. Revenue generated from royalty/licensing fees plus production costs (printing, setup, bindery services). Billed on receipt of goods.
2. Eprint Fulfillment: Digital version fulfillment including document preparation, hosting, encryption, and administrative fees. URL-based links encrypted to finite views and duration. Billed on fulfillment.
3. Copyright Permissions: Securing educational, clinical, and promotional permissions for compliant re-use and reference of copyrighted material. Professional service revenue for rights acquisition.
4. Content Translations: Professional certified translation services for publications across languages and dialects, including project management workflow with quality assurances and revision opportunities.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Reprint Nexus specializes in commercial reprint services — the licensing, production, and fulfillment of research-driven and evidence-based publications sourced from publishers and learned societies. It delivers bulk printed reprints and digital eprints through its proprietary cloud-based ECO (Enterprise Content Ordering) Platform, supported by copyright permissions acquisition and certified content translation services. The company's primary focus is serving pharmaceutical and life sciences marketing and procurement teams worldwide.

Product overview

Reprint Nexus offers a unified platform-plus-services model centered on the ECO (Enterprise Content Ordering) Platform, which serves as the cloud-based hub for managing the complete reprint purchasing workflow. The ECO Platform connects to Reprint Nexus's core fulfillment services for both printed reprints and digital eprints, enabling customers to search content via PubMed's MEDLINE-indexed database, aggregate demand across buyers for volume pricing, track orders, and manage fulfillment—all from a single interface. The product portfolio comprises three main components: the ECO Platform itself (the SaaS ordering and aggregation tool), Reprint Fulfillment Services (for printed copies), and Eprint Fulfillment Services (for digital access).

Differentiator

Problem solved

Functional benefit

Brands

• ECO Platform: Enterprise Content Ordering Platform - a branded, cloud-based application that facilitates reprint ordering and achieves savings through purchase aggregation for marketing and procurement teams.

Products and services

• ECO Platform (Enterprise Content Ordering) Cloud-based SaaS application that allows marketing and procurement teams to search content via PubMed's MEDLINE-indexed database, request quotes, aggregate group orders, track fulfillment in real-time, review proofs, and initiate re-orders. Designed for enterprise life sciences organizations to manage content purchases from inquiry to fulfillment.
• Reprint Fulfillment Services Bulk purchase, licensing, production, and global fulfillment of printed clinical content sourced from publishers and learned societies, including royalty/licensing negotiation, printing, setup, bindery, global logistics, warehousing, split delivery, and copyright compliance. Targeted at pharmaceutical and life sciences marketing teams requiring physical reprints for HCP engagement.
• Eprint Fulfillment Services Digital version procurement of copyrighted publications with document preparation, hosting, URL-based encrypted access (finite views and duration), usage tracking, and expiration management for commercial distribution. Eprint links typically delivered within 2 business days of proof approval.
• Copyright Permissions Services Professional rights acquisition service that secures educational, clinical, and promotional permissions for the compliant re-use and reference of copyrighted material from publishers and rights holders.
• Content Translation Services Professional certified translation services for publications across languages and dialects, including project management workflow with quality assurances and revision opportunities to support global marketing distribution.

Quantifiable outcome

• Significant gains in savings using collaborative approach and intelligent purchasing practices
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• ResearchGate: ResearchGate is a large-scale academic content sharing and discovery platform used heavily by life sciences professionals. While not a commercial reprint provider, it overlaps with Reprint Nexus on digital distribution of scholarly content to HCP and researcher audiences.
• Sheridan: Sheridan Press is a major commercial printing services provider with dedicated journal and book reprint capabilities. It competes with Reprint Nexus's print fulfillment operations but as a larger, diversified print services incumbent rather than a specialist reprint intermediary.

Direct peers

• Copyright Clearance Center: CCC is the dominant rights-licensing and content-reuse intermediary in the market, operating RightFind for enterprise content workflows. It directly overlaps with Reprint Nexus's copyright permissions and digital content licensing services for life sciences and academic buyers.
• Reprints Desk: Reprints Desk provides commercial article reprints, eprints, and permissions services to pharmaceutical and life sciences companies. It competes head-to-head with Reprint Nexus on the same publisher-licensed content fulfillment model and serves the same enterprise pharma customer base.

Regional players

• Access Copyright: Access Copyright is a Canadian collective management organization licensing reproduction rights to published content. It overlaps with Reprint Nexus's copyright permissions service line but is regional (Canada) and structured as a rights collective rather than a commercial reprint intermediary.
• Copyright Licensing Agency (CLA): CLA is the UK's collective licensing body for copying and reuse of published content. Comparable to Reprint Nexus on the copyright permissions and content licensing function, but regional (UK) and structured as a non-profit collective rather than a commercial intermediary.

Emerging players

• DeepDyve: DeepDyve provides rental-based and subscription access to peer-reviewed scholarly articles. It overlaps with Reprint Nexus on digital article access/eprint distribution for professional and enterprise users, but its model emphasizes rental rather than reprint licensing.
• TrendMD: TrendMD operates a content recommendation and syndication network across scholarly publisher sites. While focused on article discovery and traffic rather than reprint licensing, it is comparable as a digital content distribution and rights-aware intermediary in the scholarly publishing ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ReprintNexus
• LinkedInlinkedin.com/company/reprint-nexus

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reprint Nexus